Aehr/$AEHR

1D1W1MYTD1Y5YMAX

About Aehr

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing, and selling of advance test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
Ticker
$AEHR
Sector
Semiconductors
Primary listing
NASDAQ
Employees
138

Aehr Metrics

BasicAdvanced
$2.7B
-
-$0.23
3.18
-

What the Analysts think about Aehr

Analyst ratings (Buy, Hold, Sell) for Aehr stock.
Analyst projections of the future price of Aehr stock.

Bulls say / Bears say

Aehr entered fiscal 2027 with record quarterly bookings of $60.7 million and $100.6 million of effective backlog; management forecasts fiscal 2027 revenue of $130 million to $150 million, implying approximately 160% to 200% year-over-year growth. (Aehr fiscal 2026 results)
A $22 million follow-on order announced August 12, 2026 from Aehr’s lead AI-processor customer supports continued expansion of wafer-level burn-in capacity and provides concrete evidence of production adoption beyond evaluation activity. (Aehr AI processor order)
Growth is broadening beyond a single AI program: Aehr reported more than $8 million of new silicon-carbide wafer-level burn-in orders tied to electric-vehicle programs, while its fiscal 2026 update also highlighted follow-on silicon-photonics orders for hyperscale data-center interconnects. (Aehr silicon-carbide orders)
Customer concentration remains material: the five largest customers represented about 70% of fiscal 2026 revenue, while three customers individually contributed approximately 26%, 14%, and 11%; order delays or reductions could therefore cause significant volatility. (SEC Form 10-K)
Fiscal 2026 profitability was weak despite the late-year rebound: revenue fell to $50.0 million from $59.0 million, GAAP net loss widened to $7.1 million, and gross margin declined to 35.3% from 40.6%. (Aehr fiscal 2026 results)
The roughly $100.6 million effective backlog is not guaranteed near-term revenue: Aehr warns that customers can reschedule or cancel orders and that backlog at a given date may not indicate subsequent revenue, creating execution and timing risk against the aggressive fiscal 2027 outlook. (SEC Form 10-K)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.

Aehr Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Aehr Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Aehr

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.